Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00936546
What this trial is testing

A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy

Who this might be right for
Debilitating Fibrosing Skin Disorders (Localised Scleroderma, Eosinophilic Fasciitis)
University Hospital, Ghent 3
Testing effectiveness (Phase 2)Study completedNCT01895244
What this trial is testing

Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis

Who this might be right for
SclerodermaCardiac InvolvementAutologous Stem Cell Transplantation
University Hospital Tuebingen 44
Large-scale testing (Phase 3)Study completedNCT03313180
What this trial is testing

A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 444
Not applicableStudy completedNCT02516124
What this trial is testing

EBMT ADWP Prospective Non Interventional Study : AutoHSCT in SSc Patients

Who this might be right for
Autoimmune Diseases
European Society for Blood and Marrow Transplantation 82
Post-approval studies (Phase 4)Study completedNCT07472166
What this trial is testing

Efficacy of Tofacitinib on Skin Thickening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate

Who this might be right for
Scleroderma, Systemic
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 34
Not applicableStudy completedNCT03340194
What this trial is testing

Evaluation of Calcinosis in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
University Hospital, Lille 214
Testing effectiveness (Phase 2)Ended earlyNCT05000216
What this trial is testing

COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

Who this might be right for
Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus (SLE)Pemphigus Vulgaris+6 more
National Institute of Allergy and Infectious Diseases (NIAID) 258
Large-scale testing (Phase 3)Study completedNCT00077584
What this trial is testing

Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma

Who this might be right for
Digital UlcersSystemic Sclerosis
Actelion 188
Not applicableLooking for participantsNCT06182293
What this trial is testing

Periodontal Microbiota in Systemic Sclerosis

Who this might be right for
Scleroderma Systemic
University Hospital, Strasbourg, France 30
Not applicableStudy completedNCT06990386
What this trial is testing

Self-management Telehealth Program for Scleroderma

Who this might be right for
Scleroderma
Khon Kaen University 72
Early research (Phase 1)Study completedNCT06037577
What this trial is testing

Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Primary Sclerosing Cholangitis (PSC)Systemic Sclerosis (SSc)
ChemomAb Ltd. 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT07493395
What this trial is testing

Phase IIa Trial of Anti-CD19 CAR T-Cells in Systemic Sclerosis Resistant to Immunosuppressive Therapy

Who this might be right for
Scleroderma, Systemic
University Hospital, Montpellier 6
Early research (Phase 1)Looking for participantsNCT06414135
What this trial is testing

Relmacabtagene Autoleucel for the Treatment of Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Liangjing Lu 6
Large-scale testing (Phase 3)Study completedNCT01347008
What this trial is testing

Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis

Who this might be right for
Scleroderma, SystemicScleroderma, DiffuseScleroderma, Limited+1 more
Federal University of São Paulo 41
Not applicableLooking for participantsNCT07515638
What this trial is testing

Immun4Cure Cohort of Autoimmune Diseases

Who this might be right for
Rheumatoid ArthritisSystemic Lupus ErythematosusSystemic Sclerosis+1 more
University Hospital, Montpellier 500
Testing effectiveness (Phase 2)Study completedNCT00506831
What this trial is testing

Imatinib in Systemic Sclerosis

Who this might be right for
Scleroderma, Systemic
Stanford University 9
Not applicableStudy completedNCT04533971
What this trial is testing

The Effect of a Series of Systemic Cryotherapy Treatments on the Functional State of Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (ICD10-G35)
Pomeranian Medical University Szczecin 114
Early research (Phase 1)Looking for participantsNCT06801119
What this trial is testing

Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs）

Who this might be right for
Systemic Lupus ErythematosusSclerodermaRheumatoid Arthritis
Shenzhen MagicRNA Biotechnology Co., Ltd 30
Not applicableStudy completedNCT05907200
What this trial is testing

Ultrasound Therapy and Manual Therapy in Digital Ischemic Ulcers

Who this might be right for
Systemic Sclerosis
University of Palermo 45
Not applicableNot Yet RecruitingNCT06871644
What this trial is testing

Clinical Study of CD7 CAR-T Cells for Relapsed/refractory Autoimmune Diseases

Who this might be right for
Systemic Sclerosis - 2013 ACR/EULAR Classification Criteria
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 18
Next Page